You are here

  • Home
  • Archive
  • Volume 10, Issue 6
  • DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity

Article metrics

Article menu

This article has a correction. Please see:

Clinical/translational cancer immunotherapy
Original research
DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity

 

Online download statistics by month:

Online download statistics by month: June 2022 to February 2026

AbstractFullPdf
Jun 20229971032447
Jul 2022413424158
Aug 2022261262135
Sep 202223223981
Oct 202224124798
Nov 202220320469
Dec 202218018061
Jan 202319920068
Feb 2023208211110
Mar 2023197201100
Apr 202313613782
May 2023223224121
Jun 202312813057
Jul 202313413472
Aug 202319819984
Sep 202316016161
Oct 202318918994
Nov 202317617872
Dec 202313613868
Jan 202412913072
Feb 202416817384
Mar 2024211213123
Apr 2024176177112
May 202418418595
Jun 202419219178
Jul 2024227229222
Aug 202415314847
Sep 2024127128252
Oct 202417717766
Nov 2024306307134
Dec 2024172175105
Jan 202520720768
Feb 202516916989
Mar 202520520588
Apr 202517317362
May 202511511769
Jun 2025444425
Jul 2025220
Sep 2025110
Jan 2026001
Feb 2026110
Total775078423830